ロード中...

Carbamylated Erythropoietin Outperforms Erythropoietin in the Treatment of AKI-on-CKD and Other AKI Models

Erythropoietin (EPO) may be a beneficial tissue–protective cytokine. However, high doses of EPO are associate with adverse effects, including thrombosis, tumor growth, and hypertension. Carbamylated erythropoietin (CEPO) lacks both erythropoietic and vasoconstrictive actions. In this study, we compa...

詳細記述

保存先:
書誌詳細
出版年:J Am Soc Nephrol
主要な著者: Tögel, Florian E., Ahlstrom, Jon D., Yang, Ying, Hu, Zhuma, Zhang, Ping, Westenfelder, Christof
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Nephrology 2016
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5084891/
https://ncbi.nlm.nih.gov/pubmed/26984884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2015091059
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!